Application 202682
- Type
- ANDA
- Sponsor
- HETERO USA INC
Related Records
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 10MG | No | No |
| 002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 18MG | No | No |
| 003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 25MG | No | No |
| 004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 40MG | No | No |
| 005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 60MG | No | No |
| 006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 80MG | No | No |
| 007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 100MG | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 31722-714 | Atomoxetine | Atomoxetine | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-715 | Atomoxetine | Atomoxetine | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-716 | Atomoxetine | Atomoxetine | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-717 | Atomoxetine | Atomoxetine | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-718 | Atomoxetine | Atomoxetine | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-719 | Atomoxetine | Atomoxetine | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-720 | Atomoxetine | Atomoxetine | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 50090-6127 | Atomoxetine | Atomoxetine | A-S Medication Solutions | ANDA | Current |
| 50090-6143 | Atomoxetine | Atomoxetine | A-S Medication Solutions | ANDA | Current |
| 50090-6144 | Atomoxetine | Atomoxetine | A-S Medication Solutions | ANDA | Current |